Long-term effects of levosimendan infusion on inflammatory processes and sFas in patients with severe heart failure (Q83816869)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16713737%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

Long-term effects of levosimendan infusion on inflammatory processes and sFas in patients with severe heart failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16713737%20AND%20SRC:MED&resulttype=core&format=json

Christodoulos I. Stefanadis

28 January 2020

author

8

Christodoulos Stefanadis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16713737%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

6

Dimitris Tousoulis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16713737%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Costantinos Tentolouris

7

Costantinos Tentolouris

1 reference

28 January 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16713737%20AND%20SRC:MED&resulttype=core&format=json

Athanasios Trikas

1

Athanasios Trikas

1 reference

28 January 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16713737%20AND%20SRC:MED&resulttype=core&format=json

Karmen Vasiliadou

4

Karmen Vasiliadou

1 reference

28 January 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16713737%20AND%20SRC:MED&resulttype=core&format=json

Charalambos Antoniades

2

Charalambos Antoniades

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16713737%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Giorgos Latsios

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16713737%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Ioannis Karamitros

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16713737%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

19 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16713737%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Heart Failure

28 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16713737%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16713737%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16713737%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

804-809

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16713737%20AND%20SRC:MED&resulttype=core&format=json

Pharmacodynamics and safety of a new calcium sensitizer, levosimendan, and its metabolites during an extended infusion in patients with severe heart failure

28 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.03.003

Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.03.003

Effects of levosimendan and milrinone on oxygen consumption in isolated guinea-pig heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.03.003

Levosimendan, a new calcium-sensitizing inotrope for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.03.003

Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.03.003

Levosimendan: first in a new class of inodilator for acute and chronic severe heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.03.003

Effects of levosimendan on circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.03.003

Pharmacokinetics of levosimendan and its active metabolite OR-1896 in rapid and slow acetylators

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.03.003

A glossary of circulating cytokines in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.03.003

Systemic inflammation in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.03.003

Elevated soluble CD14 receptors and altered cytokines in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.03.003

Endotoxin and immune activation in chronic heart failure: a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.03.003

Invasive assessment of bacterial endotoxin and inflammatory cytokines in patients with acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.03.003

Selective intestinal decontamination in advanced chronic heart failure: a pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.03.003

Tumor necrosis factor in congestive heart failure: A mechanism of disease for the new millennium?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.03.003

Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.03.003

Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.03.003

Expression and Functional Significance of Tumor Necrosis Factor Receptors in Human Myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.03.003

The potential biological and clinical significance of the soluble tumor necrosis factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.03.003

Tumor necrosis factor receptors 1 and 2 differentially regulate survival, cardiac dysfunction, and remodeling in transgenic mice with tumor necrosis factor-alpha-induced cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.03.003

Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.03.003

Tumor Necrosis Factor Soluble Receptors in Patients With Various Degrees of Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.03.003

Plasma cytokine parameters and mortality in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.03.003

Activation of the NF-kappaB system in peripheral blood leukocytes from patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.03.003

Apoptosis in myocytes in end-stage heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.03.003

Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.03.003

Elevated circulating levels and cardiac secretion of soluble Fas ligand in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.03.003

Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2006.03.003

10.1016/J.EJHEART.2006.03.003

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16713737%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference